Illes A et al. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy.. (2009) SCANDINAVIAN JOURNAL OF IMMUNOLOGY 0300-9475 1365-3083 69 5 387-400,
1343769
Yadlapati Sujani et al. Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?. (2016) BIOMED RESEARCH INTERNATIONAL 2314-6133 2314-6141
Yamamoto Mitsuko et al. Lymphoma Caused by Intestinal Microbiota. (2014) INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 1661-7827 1660-4601 11 9 9038-9049
Lacerda Machado Roberta et al. Incidence of neoplasms in the most prevalent autoimmune rheumatic diseases: a systematic review. (2014) REVISTA BRASILEIRA DE REUMATOLOGIA 0482-5004 1809-4570 54 2 131-139
Chang Shih-Lun et al. Impact of head and neck malignancies on risk factors and survival in systemic lupus erythematosus. (2013) ACTA OTO-LARYNGOLOGICA 0001-6489 1651-2251 133 10 1088-1095
Nielsen SF et al. Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: A nationwide study. (2011) BLOOD 0006-4971 1528-0020 118 15 4062-4069
Szodoray P et al. Cells with regulatory function of the innate and adaptive immune system in primary Sjögren’s syndrome. (2009) CLINICAL AND EXPERIMENTAL IMMUNOLOGY 0009-9104 1365-2249 157 3 343-349,
2412558
Fasano S. et al. Pathogenesis of primary Sjogren's syndrome beyond B lymphocytes. (2020) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 0392-856X 1593-098X 38 4 S315-S323
Bax Kiley et al. Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice. (2020) CURRENT RHEUMATOLOGY REPORTS 1523-3774 1534-6307 22 3
Rizzo Chiara et al. Invariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome. (2019) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 20 21
Gianchecchi Elena et al. NK cells in autoimmune diseases: Linking innate and adaptive immune responses. (2018) AUTOIMMUNITY REVIEWS 1568-9972 17 2 142-154
Hou Ziliang et al. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis. (2017) RESPIRATORY RESEARCH 1465-9921 1465-993X 18
Liu Chen et al. Elevated level of circulating CD4(+)Helios(+)FoxP3(+) cells in primary Sjogren's syndrome patients. (2017) MODERN RHEUMATOLOGY 1439-7595 1439-7609 27 4 630-637
Narkeviciute Ieva et al. Are cytotoxic effector cells changes in peripheral blood of patients with Sjogren's syndrome related to persistent virus infection: Suggestions and conundrums. (2016) CELLULAR IMMUNOLOGY 0008-8749 1090-2163 310 123-130
Alunno A et al. T regulatory and T helper 17 cells in primary Sjögren's syndrome: Facts and perspectives. (2015) MEDIATORS OF INFLAMMATION 0962-9351 1466-1861 2015
Li X-F et al. Inhibition of SATB1 expression in regulatory T cells contributes to hepatitis B virus-related chronic liver inflammation. (2015) MOLECULAR MEDICINE REPORTS 1791-2997 1791-3004 11 1 231-236
Sudzius G et al. Distribution of peripheral lymphocyte populations in primary Sjögren's syndrome patients. (2015) JOURNAL OF IMMUNOLOGY RESEARCH 2314-8861 2314-7156 2015
Li X. Alterations of plasmacytoid dendritic cells in peripheral blood of patients with primary SjjÖgren's syndrome and their significance. (2015) CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY 0254-5101 35 2 117-120
Donate A et al. The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms. (2014) EXPERT REVIEW OF CLINICAL IMMUNOLOGY 1744-666X 1744-8409 10 4 469-481
Reksten Tove et al. Sjogren's Syndrome An Update on Epidemiology and Current Insights on Pathophysiology. (2014) ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA 1042-3699 26 1 1-+
Itoi S et al. Immunohistochemical analysis of interleukin-17 producing t helper cells and regulatory t cells infiltration in annular erythema associated with sjögren's syndrome. (2014) ANNALS OF DERMATOLOGY 1013-9087 26 2 203-208
Carrade Holt et al. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source. (2014) STEM CELLS AND DEVELOPMENT 1547-3287 1557-8534 23 11 1258-1265
Rusakiewicz S et al. Sjögren's syndrome: NCR3/NKp30 contributes to pathogenesis in primary Sjögren's syndrome. (2013) SCIENCE TRANSLATIONAL MEDICINE 1946-6234 5 195
Li CL et al. Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: An animal study. (2013) JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY 1010-5182 41 7 610-615
Alunno A et al. Characterization of a new regulatory CD4+ T cell subset in primary sjögren's syndrome. (2013) RHEUMATOLOGY (UNITED KINGDOM) 1462-0324 1462-0332 52 8 1387-1396
Qin Q. TNF receptor-associated factor 6 expression in peripheral blood mononuclear cells of patients with primary sjögren's syndrome and its cinical significance. (2012) ACADEMIC JOURNAL OF SECOND MILITARY MEDICAL UNIVERSITY 0258-879X 33 1 63-66
García-Carrasco M et al. Serologic features of primary Sjögren's syndrome: Clinical and prognostic correlation. (2012) INTERNATIONAL JOURNAL OF CLINICAL RHEUMATOLOGY 1758-4272 7 6 651-659
Busch R et al. Local activation and systemic dysregulation of T lymphocytes in Sjögren's syndrome. (2012) CURRENT PHARMACEUTICAL BIOTECHNOLOGY 1389-2010 1873-4316 13 10 2009-2021
Smoleńska Z et al. Increased percentage of CD8+CD28- T cells correlates with clinical activity in primary Sjögren's syndrome. (2012) CELLULAR IMMUNOLOGY 0008-8749 1090-2163 278 1-2 143-151
Baldini C et al. Proteomic analysis of saliva: A unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. (2011) ARTHRITIS RESEARCH & THERAPY 1478-6354 1478-6362 13 6
Chien PJ et al. Inhibition of peripheral blood natural killer cell cytotoxicity in patients with myasthenia gravis treated with plasmapheresis. (2011) EUROPEAN JOURNAL OF NEUROLOGY 1351-5101 1468-1331 18 11 1350-1357
Guo X et al. Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection. (2011) VIROLOGY JOURNAL 1743-422X 8
Michels-Van Amelsfort et al. CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases. (2011) EXPERT REVIEW OF CLINICAL IMMUNOLOGY 1744-666X 1744-8409 7 4 499-514
Li X et al. Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection. (2010) CELLULAR IMMUNOLOGY 0008-8749 1090-2163 264 1 42-46
Szodoray P et al. The immunoregulatory role of vitamins A, D and E in patients with primary Sjögren's syndrome. (2010) RHEUMATOLOGY (UNITED KINGDOM) 1462-0324 1462-0332 49 2 211-217,
2288412
Lee Jee Hye et al. The Association of Serum Vitamin D Level With the Severity of Dry Eye Parameters in Primary Sjogren Syndrome. (2020) CORNEA 0277-3740 1536-4798 39 6 702-705
Liu Ting-Ting et al. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjogren's syndrome. (2020) INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 1756-1841 23 5 654-660
Bjork A. et al. Environmental factors in the pathogenesis of primary Sjogren's syndrome. (2020) JOURNAL OF INTERNAL MEDICINE 0954-6820 1365-2796 287 5 475-492
Dikci Seyhan et al. Conjunctival impression cytology and tear-film changes in cases with vitamin D deficiency. (2020) INTERNATIONAL OPHTHALMOLOGY 0165-5701 1573-2630 40 7 1687-1694
Li Linhui et al. The association between vitamin D level and Sjogren's syndrome: A meta-analysis. (2019) INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 1756-1841 22 3 532-533
Murdaca Giuseppe et al. Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications. (2019) AUTOIMMUNITY REVIEWS 1568-9972 18 9
Zhang L -W et al. Expression of interleukin-17 in primary Sjogren's syndrome and the correlation with disease severity: A systematic review and meta-analysis. (2018) SCANDINAVIAN JOURNAL OF IMMUNOLOGY 0300-9475 1365-3083 87 4
Sandhya Pulukool et al. Vitamin D Levels and Associations in Indian Patients with Primary Sjogren's Syndrome. (2017) JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 2249-782X 0973-709X 11 9 OC33-OC36
Watad Abdulla et al. Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity. (2017) JOURNAL OF AUTOIMMUNITY 0896-8411 1095-9157 82 13-30
Slebioda Zuzannna et al. Vitamin D and Its Relevance in the Etiopathogenesis of Oral Cavity Diseases. (2016) ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS 0004-069X 1661-4917 64 5 385-397
Faustino Jacqueline Ferreira et al. Vitamin A and the eye: an old tale for modern times. (2016) ARQUIVOS BRASILEIROS DE OFTALMOLOGIA 0004-2749 1678-2925 79 1 56-61
Luzmila Riega-Torres Janett et al. Sjogren's syndrome (SS), a review of the subject and saliva as a diagnostic method. (2016) GACETA MEDICA DE MEXICO 0016-3813 152 3 371-380
Lee Sang Jin et al. Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome. (2016) JOURNAL OF IMMUNOLOGY RESEARCH 2314-8861 2314-7156 2016
Zardi Enrico Maria et al. Levels of Vitamin D, Disease Activity and Subclinical Atherosclerosis in Post-menopausal Women with Sjogren's Syndrome: Does a Link Exist?. (2016) IN VIVO 0258-851X 1791-7549 30 5 721-725
Kurtul BE. The association of Vitamin D deficiency with tear break-up time and Schirmer testing in non-Sjögren dry eye. (2015) Eye (Basingstoke) 29 8 1081-1084
Erten Sukran et al. Comparison of plasma vitamin D levels in patients with Sjogren's syndrome and healthy subjects. (2015) INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 1756-1841 18 1 70-75
Baldini C et al. Vitamin D in "early" primary Sjögren's syndrome: Does it play a role in influencing disease phenotypes?. (2014) RHEUMATOLOGY INTERNATIONAL 0172-8172 1437-160X 34 8 1159-1164
Agmon-Levin Nancy et al. Vitamin D in Systemic and Organ-Specific Autoimmune Diseases. (2013) CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY 1080-0549 45 2 256-266
Agmon-Levin Nancy et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome. (2012) JOURNAL OF AUTOIMMUNITY 0896-8411 1095-9157 39 3 234-239
Szodoray Peter et al. The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation. (2010) AUTOIMMUNITY REVIEWS 1568-9972 9 6 459-464,
1914375
Oka Takashi et al. Sensitive Photodynamic Detection of Adult T-cell Leukemia/Lymphoma and Specific Leukemic Cell Death Induced by Photodynamic Therapy: Current Status in Hematopoietic Malignancies. (2020) CANCERS 2072-6694 12 2
Dieterlen Maja-Theresa et al. Indication-specific immunomodulatory effects of extracorporeal photopheresis: A pilot study in heart transplanted patients. (2018) JOURNAL OF CLINICAL APHERESIS 0733-2459 33 5 591-599
Holien Toril et al. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo. (2018) LASERS IN SURGERY AND MEDICINE 0196-8092 1096-9101 50 5 469-475
Yang Huamei et al. Possible alternative therapies for oral lichen planus cases refractory to steroid therapies. (2016) ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY 2212-4403 2212-4411 121 5 496-509
Hu X. Previously Activated Psoralen: A Possible Novel Format of Psoralen Used in the Treatment of Graft-versus-host Disease. (2015) WEST INDIAN MEDICAL JOURNAL 0043-3144 0368-1238 64 2 135-137
Ratcliffe Nora et al. National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis. (2015) TRANSFUSION MEDICINE REVIEWS 0887-7963 29 1 62-70
Weitz Marcus et al. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. (2015) COCHRANE DATABASE OF SYSTEMATIC REVIEWS 1469-493X 12
Weitz Marcus et al. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. (2015) COCHRANE DATABASE OF SYSTEMATIC REVIEWS 1469-493X 12
Kyagova A et al. Photohemolysis sensitized by the furocoumarin derivative alloimperatorin and its hydroperoxide photooxidation product. (2014) PHOTOCHEMISTRY AND PHOTOBIOLOGY 0031-8655 1751-1097 90 1 162-170
Weitz Marcus et al. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. (2014) COCHRANE DATABASE OF SYSTEMATIC REVIEWS 1469-493X 2
Weitz Marcus et al. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. (2014) COCHRANE DATABASE OF SYSTEMATIC REVIEWS 1469-493X 2
Quaglino P et al. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: A single center clinical experience with long-term follow-up data and a brief overview of the literature. (2013) INTERNATIONAL JOURNAL OF DERMATOLOGY 0011-9059 1365-4632 52 11 1308-1318
Jain M et al. Emerging trends for radioimmunotherapy in solid tumors. (2013) CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 1084-9785 1557-8852 28 9 639-650
Barr ML. Call it BOS, call it CLAD-the need for prospective clinical trials and elucidating the mechanism of extracorporeal photopheresis. (2013) AMERICAN JOURNAL OF TRANSPLANTATION 1600-6135 1600-6143 13 4 833-834
Baroudjian B et al. Long-term efficacy of extracorporeal photochemotherapy in a patient with refractory epidermolysis bullosa acquisita. (2012) EUROPEAN JOURNAL OF DERMATOLOGY 1167-1122 1952-4013 22 6 795-797
Daniele N et al. Evaluation of cell death after treatment with extracorporeal photopheresis. (2012) TRANSFUSION AND APHERESIS SCIENCE 1473-0502 1878-1683 46 1 53-57
Merlin E et al. Use of cryopreserved autologous cells for extracorporeal photochemotherapy: Clinical applications. (2011) TRANSFUSION 0041-1132 1537-2995 51 6 1296-1299
Kofoed K et al. Der er dokumenteret effekt af ekstrakorporal fotoferese ved T-celle-medierede sygdomme. (2011) UGESKRIFT FOR LAEGER 0041-5782 1603-6824 173 26 1869-1874
Merlin E et al. Cryopreservation of mononuclear cells before extracorporeal photochemotherapy does not impair their anti-proliferative capabilities. (2011) CYTOTHERAPY 1465-3249 1477-2566 13 2 248-255
Marenco F et al. High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. (2010) DERMATOLOGIC THERAPY 1396-0296 23 4 419-422
Csiki Z et al. The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud's syndrome. (2011) MICROVASCULAR RESEARCH 0026-2862 1095-9319 82 1 84-87,
2189052
Sebestyén Veronika et al. Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis. (2020) RHEUMATOLOGY (UNITED KINGDOM) 1462-0324 1462-0332 59 3 478-486
Bienias Piotr et al. Comparison of non-invasive assessment of arrhythmias, conduction disturbances and cardiac autonomic tone in systemic sclerosis and systemic lupus erythematosus. (2019) RHEUMATOLOGY INTERNATIONAL 0172-8172 1437-160X 39 2 301-310
Molnár I et al. Effects of neural therapy on quality of life in patients suffering from Raynaud syndrome. (2018) EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE 1876-3820 18 59-65